Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Fulda

Showing results (41-50 of 287) with videos related to

Pageof 29
Sort By:
Oncotarget|July 27, 2011
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the linkSimone Fulda
Cancer Treatment Reviews|February 21, 2012
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancersSimone Fulda
Sarcoma|February 2, 2012
Cell death pathways as therapeutic targets in rhabdomyosarcomaSimone Fulda
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Regulation of cell death and survival by resveratrol: implications for cancer therapySimone Fulda
Frontiers in Oncology|February 20, 2013
How to target apoptosis signaling pathways for the treatment of pediatric cancersSimone Fulda
Expert Opinion on Therapeutic Targets|December 21, 2012
Targeting c-FLICE-like inhibitory protein (CFLAR) in cancerSimone Fulda
Biological Chemistry|May 14, 2016
Mitochondria, redox signaling and cell death in cancerSimone Fulda
Mitochondrion|May 1, 2014
Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signalingSimone Fulda
Frontiers in Oncology|January 31, 2014
Inhibitor of apoptosis proteins in pediatric leukemia: molecular pathways and novel approaches to therapySimone Fulda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
Molecular pathways: targeting death receptors and smac mimeticsSimone Fulda
Pageof 29

Showing results (41-50 of 287) with videos related to

Sort By:
Pageof 29
Oncotarget|July 27, 2011
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the linkSimone Fulda
Cancer Treatment Reviews|February 21, 2012
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancersSimone Fulda
Sarcoma|February 2, 2012
Cell death pathways as therapeutic targets in rhabdomyosarcomaSimone Fulda
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Regulation of cell death and survival by resveratrol: implications for cancer therapySimone Fulda
Frontiers in Oncology|February 20, 2013
How to target apoptosis signaling pathways for the treatment of pediatric cancersSimone Fulda
Expert Opinion on Therapeutic Targets|December 21, 2012
Targeting c-FLICE-like inhibitory protein (CFLAR) in cancerSimone Fulda
Biological Chemistry|May 14, 2016
Mitochondria, redox signaling and cell death in cancerSimone Fulda
Mitochondrion|May 1, 2014
Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signalingSimone Fulda
Frontiers in Oncology|January 31, 2014
Inhibitor of apoptosis proteins in pediatric leukemia: molecular pathways and novel approaches to therapySimone Fulda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2014
Molecular pathways: targeting death receptors and smac mimeticsSimone Fulda
Pageof 29